In the past week, PRVA stock has gone down by -4.03%, with a monthly decline of -11.37% and a quarterly plunge of -14.67%. The volatility ratio for the week is 3.76%, and the volatility levels for the last 30 days are 4.24% for Privia Health Group Inc The simple moving average for the past 20 days is -6.16% for PRVA’s stock, with a -21.51% simple moving average for the past 200 days.
Is It Worth Investing in Privia Health Group Inc (NASDAQ: PRVA) Right Now?
Privia Health Group Inc (NASDAQ: PRVA) has a higher price-to-earnings ratio of 96.38x compared to its average ratio, The 36-month beta value for PRVA is at 0.84. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PRVA is 101.89M, and currently, shorts hold a 6.58% of that float. The average trading volume for PRVA on April 18, 2024 was 985.18K shares.
PRVA) stock’s latest price update
The stock price of Privia Health Group Inc (NASDAQ: PRVA) has surged by 0.90 when compared to previous closing price of 17.69, but the company has seen a -4.03% decline in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-09 that ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.
Analysts’ Opinion of PRVA
Many brokerage firms have already submitted their reports for PRVA stocks, with Barclays repeating the rating for PRVA by listing it as a “Equal Weight.” The predicted price for PRVA in the upcoming period, according to Barclays is $22 based on the research report published on March 06, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see PRVA reach a price target of $25, previously predicting the price at $33. The rating they have provided for PRVA stocks is “Buy” according to the report published on February 26th, 2024.
BofA Securities gave a rating of “Neutral” to PRVA, setting the target price at $21 in the report published on February 22nd of the current year.
PRVA Trading at -11.71% from the 50-Day Moving Average
After a stumble in the market that brought PRVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.80% of loss for the given period.
Volatility was left at 4.24%, however, over the last 30 days, the volatility rate increased by 3.76%, as shares sank -14.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.56% lower at present.
During the last 5 trading sessions, PRVA fell by -4.03%, which changed the moving average for the period of 200-days by -31.64% in comparison to the 20-day moving average, which settled at $18.87. In addition, Privia Health Group Inc saw -22.49% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PRVA starting from Mountcastle David, who sale 3,933 shares at the price of $17.77 back on Apr 02 ’24. After this action, Mountcastle David now owns 262,279 shares of Privia Health Group Inc, valued at $69,889 using the latest closing price.
Sullivan William M, the Director of Privia Health Group Inc, sale 400 shares at $23.02 during a trade that took place back on Mar 11 ’24, which means that Sullivan William M is holding 5,445,018 shares at $9,208 based on the most recent closing price.
Stock Fundamentals for PRVA
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.1 for the gross margin
The net margin for Privia Health Group Inc stands at 0.01. The total capital return value is set at 0.03. Equity return is now at value 4.35, with 2.55 for asset returns.
Based on Privia Health Group Inc (PRVA), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 10.13. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -0.01.
Currently, EBITDA for the company is 27.18 million with net debt to EBITDA at -14.02. When we switch over and look at the enterprise to sales, we see a ratio of 1.05. The receivables turnover for the company is 5.7for trailing twelve months and the total asset turnover is 1.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.
Conclusion
In conclusion, Privia Health Group Inc (PRVA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
